Avid Bioservices, Inc.
CDMO · NASDAQ
4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | |
|---|---|---|---|---|
| Market Cap | $482 | $1,106 | $828 | $1,246 |
| - Cash | $38 | $39 | $126 | $170 |
| + Debt | $208 | $189 | $183 | $118 |
| Enterprise Value | $652 | $1,257 | $884 | $1,195 |
| Revenue | $140 | $149 | $120 | $96 |
| % Growth | -6.3% | 24.8% | 24.8% | – |
| Gross Profit | $7 | $31 | $37 | $29 |
| % Margin | 5.2% | 21.1% | 30.6% | 30.6% |
| EBITDA | -$11 | $11 | $20 | $16 |
| % Margin | -8.2% | 7.3% | 16.6% | 16.4% |
| Net Income | -$141 | $1 | $128 | $11 |
| % Margin | -100.6% | 0.4% | 106.8% | 11.7% |
| EPS Diluted | -2.23 | 0.009 | 1.81 | 0.056 |
| % Growth | -25,440.9% | -99.5% | 3,143.7% | – |
| Operating Cash Flow | $11 | -$13 | $9 | $31 |
| Capital Expenditures | -$32 | -$78 | -$56 | -$10 |
| Free Cash Flow | -$21 | -$91 | -$47 | $21 |